Your browser is no longer supported. Please, upgrade your browser.
Settings
AKTX Akari Therapeutics, Plc daily Stock Chart
AKTX [NASD]
Akari Therapeutics, Plc
Index- P/E- EPS (ttm)-2.68 Insider Own4.93% Shs Outstand14.86M Perf Week-18.06%
Market Cap61.37M Forward P/E- EPS next Y-2.79 Insider Trans0.00% Shs Float5.72M Perf Month-3.50%
Income-31.60M PEG- EPS next Q-0.66 Inst Own15.30% Short Float8.89% Perf Quarter-23.66%
Sales- P/S- EPS this Y71.00% Inst Trans-25.84% Short Ratio0.94 Perf Half Y-13.60%
Book/sh1.11 P/B3.72 EPS next Y-34.80% ROA-92.30% Target Price8.75 Perf Year-50.72%
Cash/sh1.41 P/C2.92 EPS next 5Y- ROE-136.70% 52W Range3.18 - 22.20 Perf YTD-41.34%
Dividend- P/FCF- EPS past 5Y38.70% ROI- 52W High-81.40% Beta-8.28
Dividend %- Quick Ratio2.40 Sales past 5Y- Gross Margin- 52W Low29.74% ATR0.42
Employees15 Current Ratio2.40 Sales Q/Q- Oper. Margin- RSI (14)34.62 Volatility12.61% 9.49%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.94 Prev Close4.26
ShortableYes LT Debt/Eq0.00 EarningsNov 30 Payout- Avg Volume542.14K Price4.13
Recom1.70 SMA20-12.31% SMA50-15.14% SMA200-37.57% Volume511,097 Change-3.05%
Sep-22-17Upgrade William Blair Mkt Perform → Outperform
May-31-17Upgrade Chardan Capital Markets Sell → Neutral $6
Apr-17-17Reiterated Chardan Capital Markets Sell $6.50 → $5
Jul-11-16Initiated Chardan Capital Markets Sell $5
Dec-13-17 08:57AM  Syros Pharmaceuticals (SYRS) in Focus: Stock Moves 12.7% Higher Zacks
08:47AM  Tenet Healthcare (THC) in Focus: Stock Moves 8.5% Higher Zacks
Dec-12-17 07:40AM  Wired News Akaris Phase-II COBALT Trial of Coversin in Patients with PNH Met the Primary Endpoint ACCESSWIRE -9.01%
Dec-11-17 08:41AM  Alexion (ALXN) in Focus: Stock Moves 7.2% Higher Zacks
Dec-08-17 04:05PM  Akari Therapeutics Announces Phase II COBALT trial of Coversin in Patients with PNH Met the Primary Endpoint GlobeNewswire
Dec-06-17 08:53AM  Why AveXis (AVXS) Could Be Positioned for a Slump Zacks
Dec-04-17 04:01PM  Akari Therapeutics to Host Investor and Analyst Event During the 59th American Society of Hematology Meeting GlobeNewswire
Dec-01-17 09:33AM  Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime Zacks
Nov-30-17 08:20AM  5 Affordable Breakout Stocks Offering Excellent Returns Zacks
08:00AM  Akari: December Coversin Update, Analysts Opinion and Catalysts ACCESSWIRE
Nov-27-17 08:51AM  ANI Pharmaceuticals (ANIP) Catches Eye: Stock Jumps 17.7% Zacks
Oct-18-17 09:00AM  Akari Therapeutics Announces Pricing of Public Offering of American Depositary Shares GlobeNewswire -29.69%
Oct-17-17 04:01PM  Akari Therapeutics Announces Proposed Public Offering of American Depositary Shares GlobeNewswire
Oct-13-17 07:10AM  Corporate News Blog - Akari Therapeutics Announces Enrolment of Additional Patients in COBALT Phase-II Clinical Trial of Coversin(TM) ACCESSWIRE -8.91%
Oct-12-17 08:20AM  Today's Research Reports on Stocks to Watch: Akari Therapeutics and Seattle Genetics ACCESSWIRE -5.95%
Oct-11-17 07:00AM  Akari Therapeutics Announces Further Clinical Progress GlobeNewswire +22.72%
Sep-22-17 01:42PM  Akari Therapeutics Rally Continues As William Blair Upgrades Benzinga -6.41%
08:25AM  Werner Enterprises, Cott, Akari Therapeutics, and Alexion highlighted as Zacks Bull and Bear of the Day Zacks
08:20AM  Today's Research Reports on Stocks to Watch: Akari Therapeutics and Intercept Pharmaceuticals ACCESSWIRE
Sep-21-17 02:10PM  Akari Therapeutics (AKTX) Stock is Skyrocketing Over 60% Today: Here's Why Zacks +56.35%
07:00AM  Akari Therapeutics Announces Regulatory Progress Following FDA Meeting GlobeNewswire
Sep-19-17 07:00AM  Akari Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-12-17 08:47AM  Idera Pharmaceuticals (IDRA) Jumps: Stock Rises 14.4% Zacks +21.62%
Sep-11-17 08:42AM  NewLink Genetics (NLNK) Jumps: Stock Rises 29.9% Zacks +20.25%
Sep-06-17 08:46AM  Regenxbio (RGNX) in Focus: Stock Moves 9.5% Higher Zacks
Aug-21-17 07:05AM  Akari Therapeutics Announces Appointment of David Horn Solomon as CEO GlobeNewswire
Aug-10-17 07:00AM  Akari Therapeutics to Present at the 37th Annual Canaccord Genuity Growth Conference GlobeNewswire -6.70%
Jul-11-17 10:39AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) and Lead Plaintiff Deadline - - July 11, 2017 Accesswire
Jul-10-17 10:50PM  AKARI THERAPEUTICS 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; CLAIMSFILER REMINDS INVESTORS of Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc (AKTX) GlobeNewswire +8.29%
01:07PM  DEADLINE TOMORROW: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm GlobeNewswire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 GlobeNewswire
Jul-07-17 11:58PM  JULY 11 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire -9.44%
10:50PM  AKARI THERAPEUTICS 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Akari Therapeutics, Plc (AKTX) Business Wire
07:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akari Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - AKTX PR Newswire
10:38AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) and Lead Plaintiff Deadline - - July 11, 2017 Accesswire
10:30AM  July 11 Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akari Therapeutics, Plc Business Wire
Jul-06-17 12:19PM  5-DAY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm Accesswire
10:35AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 Accesswire
Jul-05-17 06:05PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm Business Wire
05:21PM  DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
03:47PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akari Therapeutics, Plc - AKTX PR Newswire
Jul-04-17 01:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akari Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - AKTX Accesswire
Jul-03-17 03:51PM  EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm Accesswire
10:45AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 Accesswire
Jun-30-17 11:51PM  APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc (AKTX) GlobeNewswire
02:58PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akari Therapeutics plc of Class Action Lawsuit and Upcoming Deadline AKTX GlobeNewswire
10:37AM  INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) and Lead Plaintiff Deadline - - July 11, 2017 Accesswire
Jun-29-17 05:18PM  INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm Accesswire
10:34AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 Accesswire
Jun-26-17 04:43PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
10:36AM  INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) and Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-23-17 11:59PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm Accesswire +8.18%
04:48PM  Akari Notice: Rosen Law Firm Reminds Akari Therapeutics, Plc Investors of Important Deadline in Class Action - AKTX GlobeNewswire
07:00AM  Akari Therapeutics to Present Data from Phase 2 PNH Trial of Coversin at the 22nd Congress of the European Hematology Association GlobeNewswire
Jun-22-17 02:16PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire -5.17%
10:34AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-21-17 05:28PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire +5.89%
10:36AM  INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) and Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-20-17 01:48PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire +5.56%
Jun-19-17 05:59PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm Business Wire -5.86%
03:36PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire
10:35AM  INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-16-17 10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Akari Therapeutics, Plc (AKTX) Business Wire +14.90%
Jun-15-17 04:36PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire -10.92%
10:32AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-14-17 04:11PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire
01:00PM  URGENT: Monteverde & Associates PC Reminds Shareholders of Class Action Against Akari Therapeutics, Plc - AKTX & July 11th, 2017 Lead Plaintiff Deadline Accesswire
Jun-13-17 10:42AM  INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 Accesswire
Jun-12-17 11:45AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm GlobeNewswire -6.43%
10:35AM  INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 Accesswire
Jun-09-17 11:00PM  URGENT: Monteverde & Associates PC Invites Akari Therapeutics, Plc. Shareholders with Losses to Contact the Firm Immediately - AKTX Accesswire -5.37%
Jun-08-17 02:38PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 GlobeNewswire
Jun-07-17 04:11PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Akari Therapeutics, Plc (Nasdaq: AKTX) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire -5.18%
Jun-06-17 06:38PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm GlobeNewswire
05:47PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akari Therapeutics, Plc - AKTX GlobeNewswire
Jun-02-17 11:54PM  EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire +7.87%
10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc - (AKTX) PR Newswire
12:13PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Akari Therapeutics, Plc to Contact the Firm Accesswire
10:31AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-01-17 05:19PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
02:54PM  URGENT: Monteverde & Associates PC Invites Akari Therapeutics, Plc. Shareholders with Significant Losses To Contact The Firm Immediately - AKTX PR Newswire
May-31-17 08:38PM  INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
09:54AM  Biotech Movers: Akari, Array, Amicus TheStreet.com
May-30-17 07:40PM  [$$] Akari Therapeutics CEO Resigns The Wall Street Journal -10.89%
06:02PM  Akari Therapeutics Announces Resignation of CEO Business Wire
01:43PM  Lifshitz & Miller LLP Announces Investigation of Akari Therapeutics, Plc, Alexion Pharmaceuticals, Inc., Amgen Inc., Cel-Sci Corp., Dick's Sporting Goods, Inc., Eco Science Solutions, Inc., Intra-Cellular Therapies, Inc. and Twilio Inc. PR Newswire
May-25-17 02:37PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm GlobeNewswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 GlobeNewswire
May-23-17 04:53PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm GlobeNewswire -6.15%
04:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Akari Therapeutics, Plc to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
04:32PM  AKTX LOSS NOTICE: Rosen Law Firm Reminds Akari Therapeutics, Plc Investors of Important Deadline in Class Action - AKTX Business Wire
12:37PM  Investor Alert: Kaplan Fox Announces Investigation Of Akari Therapeutics, PLC PR Newswire
12:24PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc Accesswire
May-22-17 07:40PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm PR Newswire +5.09%
05:56PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm PR Newswire
08:52AM  Amgen Evenity Approval Derailed on Cardiovascular Side Effect Zacks
May-20-17 01:39PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
May-19-17 10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc - (AKTX) Marketwired
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases. Its lead drug candidate is Coversin, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barre syndrome, and atypical hemolytic uremic syndrome. The company is based in New York, New York. Akari Therapeutics, Plc is a subsidiary of RPC Pharma Limited.